Development of Kaposi's sarcoma in liver transplant recipients: characteristics, management, and outcome.
Bismuth
H
H
Hepatobiliary and Liver Transplant Research Unit, Hopital Paul Brousse, Villejuif, France.
Samuel
D
D
Venancie
P Y
PY
Menouar
G
G
Szekely
A M
AM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D011379:Prognosis; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology*; D012737:Sex Factors
D000970:Antineoplastic Agents; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents